Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
3.060
+0.170 (5.88%)
At close: Apr 28, 2026, 4:00 PM EDT
3.070
+0.010 (0.33%)
After-hours: Apr 28, 2026, 7:32 PM EDT
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $299.49 million as of April 28, 2026. Its market cap has increased by 225.18% in one year.
Market Cap
299.49M
Enterprise Value
170.95M
1-Year Change
225.18%
Ranking
Category
Stock Price
$3.06
Market Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $649.70M to $299.49M, a decrease of -53.90%. That is a compound annual growth rate of -7.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 282.90M | 41.38% |
| Dec 31, 2025 | 200.10M | 90.94% |
| Dec 31, 2024 | 104.80M | -87.33% |
| Dec 29, 2023 | 827.40M | 35.66% |
| Dec 30, 2022 | 609.90M | -66.42% |
| Dec 31, 2021 | 1.82B | -58.45% |
| Dec 31, 2020 | 4.37B | 187.69% |
| Dec 31, 2019 | 1.52B | 39.66% |
| Dec 31, 2018 | 1.09B | -15.40% |
| Dec 29, 2017 | 1.29B | 122.48% |
| Dec 30, 2016 | 577.90M | -11.05% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LENZ Therapeutics | 294.10M |
| Compugen | 293.12M |
| Minerva Neurosciences | 288.26M |
| NovaBridge Biosciences | 283.34M |
| Zentalis Pharmaceuticals | 282.31M |
| AC Immune | 281.73M |
| C4 Therapeutics | 281.03M |
| Cellectis | 280.95M |